What is Mosh?
Mosh operates at the intersection of consumer health and personalized medicine, providing a specialized telehealth platform dedicated to hair loss treatment. By streamlining the consultation and delivery process, the company removes the friction typically associated with clinical hair loss management. The platform offers a bespoke approach, where treatment plans are tailored to individual needs and delivered directly to the user's door, effectively digitizing the patient journey. This model positions Mosh as a formidable player in the direct-to-consumer health space, where convenience and clinical efficacy are paramount to maintaining high customer retention rates and long-term brand loyalty.
How much funding has Mosh raised?
Mosh has raised a total of $25M across 1 funding round:
Other Financing Round
$25M
Other Financing Round (2022): $25M with participation from Regal Funds Management
Key Investors in Mosh
Regal Funds Management
Regal Funds Management is a prominent Australian alternative investment manager known for its sophisticated long/short strategies and extensive fundamental research capabilities across private markets and equities.
What's next for Mosh?
Looking ahead, the strategic deployment of this capital will likely focus on enhancing the company's digital infrastructure and expanding its product portfolio. As Mosh scales, the focus will shift toward optimizing supply chain logistics and deepening its clinical research partnerships to maintain a competitive edge in the hair loss market. Furthermore, the company is expected to leverage its data-driven insights to improve patient outcomes, potentially exploring new therapeutic areas within the broader wellness and personal care ecosystem. This phase of growth is critical for establishing Mosh as a dominant, high-authority entity in the telehealth sector, setting the stage for future market consolidation or potential strategic partnerships.
See full Mosh company page
